好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Louisiana’s Stroke System of Care – Progress in Recanalization Therapy
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
3-067
We sought to evaluate trends in thrombolysis and thrombectomy in Louisiana.
Thrombolysis and thrombectomy treatment rates for acute ischemic stroke (AIS) are increasing based on national databases.  The Louisiana Emergency Response Network’s stroke system of care was initiated in 2010.  After randomized controlled trials demonstrated efficacy of thrombectomy, the initial destination protocol for suspected stroke was revised in early 2017 based on Mission Lifeline Stroke recommendations. 
Louisiana Hospital Discharge Dataset was examined for changes in AIS volume and rates of intravenous thrombolysis and/or thrombectomy over an 8-year period. 

The dataset includes 73,216 patients discharged with AIS with increasing yearly volume.  The thrombolytic treatment rate increased from 4.3% in 2010 to 7.2%, 8.0%, 8.9%, 8.9%, 8.1%, 11.2%, and 16.1% over subsequent years.  In 2017, a patient was 3.27x more likely and 1.53x more likely to receive thrombolytic than in 2010 and 2016, respectively (both p<0.001).  The rate of thrombectomy increased from 0.8% in 2014 to 6.4% in 2017; a patient was 8.58x more likely to have thrombectomy in 2017 than 2014 and 1.77x more likely in 2017 than 2016.  In comprehensive stroke centers, 41.3% of all AIS patients received some form of recanalization therapy compared with 21.4% in primary stroke centers, 6.3% in stroke enabled hospitals, and 1.4% in stroke bypass hospitals.

In 2010, one out of every 25 patients discharged after AIS received recanalization therapy; in 2017, one out of every 5 patients was treated.  While we cannot determine relative contribution of aspects of the system of care, the trends in recanalization therapy suggest Louisiana has been successful in improving access to time-sensitive care.

Authors/Disclosures
Sheryl Martin-Schild, MD, PhD, FAAN (Dr. Brain, Inc.)
PRESENTER
No disclosure on file
Digvijaya D. Navalkele, MD (Emory University) Dr. Navalkele has nothing to disclose.
Ramy El Khoury, MD, FAAN (Neuro Care of Louisiana) No disclosure on file
Oleg Y. Chernyshev, MD, PhD, FAAN (LSUHSC-Shreveport) Dr. Chernyshev has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file